Bill > H0599

This bill amends existing Florida law to expand the role of consultant pharmacists. Key provisions include: 1. Revising the definition of "practice of the profession of pharmacy" to include the ordering and evaluating of laboratory/clinical testing, conducting patient assessments, and modifying, discontinuing, or administering medicinal drugs by a consultant pharmacist. 2. Requiring additional training for pharmacists to be licensed as a consultant pharmacist. 3. Authorizing consultant pharmacists to provide medication management services within the framework of a written collaborative practice agreement with a healthcare facility or prescribing healthcare practitioner. This allows the consultant pharmacist to order/evaluate tests, conduct patient assessments, and modify/discontinue medications, but prohibits them from diagnosing diseases. 4. Mandating consultant pharmacists and collaborating practitioners maintain written agreements that must be available upon request. 5. Defining "health care facility" to include various inpatient and outpatient settings where consultant pharmacists can provide these expanded services. The bill aims to expand the role of consultant pharmacists in managing patient drug therapy and monitoring health status, in coordination with prescribing practitioners, within healthcare facilities.

Health and Social Services

Health and Human Services Committee (House), Health Quality Subcommittee (House)

https://www.flsenate.gov/Session/Bill/2020/599